To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial. It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB." –Dr. William Jacobs, Jr.

(Bronx, NY)—In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.

TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.

The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr. Ph.D., professor of microbiology and microbiology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences. (Photo by: Shaun W)

Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol.

"We hypothesized that TB bacteria that can't make mycothiol might contain more cysteine, an amino acid," said Dr. Jacobs. "So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected."

The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a "reducing agent" that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.

"To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C," said Dr. Jacobs. "The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains."

To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial," said Dr. Jacobs. "It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB."

The paper is titled, "Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction." The other contributors are Catherine Vilcheze, Ph.D., Travis Hartman and Brian Weinrick, Ph.D., all at Einstein.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Prayer Alert: In Nepal, the Flood Isn't the Only Dangerous Issue for Christians There (Video)

Video of Mamdani, AOC Laughing and Smiling as Names of 9/11 Victims Are Read Goes Viral (Watch)

Guess Who Helped Doxx the Holdout Juror in the Lindsay Clancy Case

AI Company Reports Attempts to Create Bioweapons and Malicious Cyberattacks

Teachers' Union Getting Involved in the Lawsuits Involving Illegal CDL Drivers; Are They Driving School Buses Too?!

Trump-Appointed Judge Blocks USPS Mail-Ballot Rule in Major Election Case

WATCH: Newly Declassified Video Shows Rescue of Air Force Pilots after Crashing in Iran; 44 Bravo's Amazing Survival Account

Riveting, Inspirational Account of the Pilot Slated to Fly Flight 11 Out of Boston on 9/11--but Didn't (Video)

Saved from the Ashes of 9/11, He Has Given His Life to Save Others Too: 'Call on Jesus'

What the White House Faith Office Has Done in Just 18 Months

Droves of Subscribers Cancel Netflix After 'Neck Injury' Joke on One-Year Anniversary of Charlie Kirk Assassination

Robert Kennedy, Jr. Delivers ABSOLUTELY HISTORIC Speech at RNC Midterm Convention in Crushing Blow to Democrat Anti-Americanism (VIDEO)

Powerful: Former Air Force Lieutenant Was Sent on Suicide Mission to Ram Flight 93-Its Brave Passengers Made Sure She Never Had To (Video)

25 Years Since 9/11

A Minute By Minute Chronology of Sept. 11, 2001 Terror Attacks

100 Million Americans Have No Memory of 9/11. Here's What's on the Line

On 25th Anniversary of the 9/11 Attacks, Many Will Excise the Most Relevant Truth From National Memory: Islamist Ideology Still Motivates Mass Murder

Marco Rubio Hails Ecuador as an 'Aggressive' Partner in the US Counterdrug Push; Receives Country's 2nd Highest Honor

Iran's Islamic Regime is Slowly Crumbling from US Blockade, as Iran's People Begin Attacking Them from Within

Dem Candidate for Senate, James Talarico Just Did a Major About-Face on Trans Athletes: 'Political Game?' (Video)

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor